Dr. Zirwas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Bexley Dermatology - DGC
2359 East Main Street
Bexley, OH 43209Phone+1 614-947-1716- Is this information wrong?
Education & Training
UPMC Medical EducationResidency, Dermatology, 2001 - 2004- UPMC Medical EducationInternship, Internal Medicine, 2000 - 2001
University of Pittsburgh School of MedicineClass of 2000
Certifications & Licensure
OH State Medical License 2004 - 2025
TN State Medical License 2019 - 2022
SC State Medical License 2012 - 2017
TX State Medical License 2012 - 2012
PA State Medical License 2001 - 2006- American Board of Dermatology Dermatology
Clinical Trials
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: a 52-week, phase 2, open-label trial.Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris, Melinda J Gooderham, H Chih-Ho Hong, Steven E Kempers, Leon H Kircik, Mark Le...> ;Journal of the American Academy of Dermatology. 2024 Mar 29
- 1 citationsRoflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B Forman, Melinda Gooderham, Lawrence Green, Scott T Guenth...> ;Journal of the American Academy of Dermatology. 2024 May 1
- Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.Lewitt, G., Glover, H., Chao, T., Brown, P., Tallman, A., Kircik, L., Zirwas, M., Kwatra, S., Rubenstein, D.> ;Dermatology and Therapy. 2024 Jan 1
- Join now to see all
Press Mentions
Challenging Cases in Atopic DermatitisDecember 7th, 2022- What Patients Need to Know About New JAK Topical Inhibitor - Dermatology Times October 2nd, 2021
- Clinical Challenges: Chronic Itch in Atopic DermatitisAugust 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
